ID   SUBB_ECOLX              Reviewed;         141 AA.
AC   Q6EZC3;
DT   28-MAR-2018, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   03-AUG-2022, entry version 40.
DE   RecName: Full=Subtilase cytotoxin subunit B {ECO:0000303|PubMed:15226357};
DE   Flags: Precursor;
GN   Name=subB {ECO:0000303|PubMed:15226357};
OS   Escherichia coli.
OG   Plasmid megaplasmid pO113 {ECO:0000312|EMBL:AAT68784.1}.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=562;
RN   [1] {ECO:0000312|EMBL:AAT68784.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=O113:H21 / 98NK2 / STEC; PLASMID=megaplasmid pO113;
RX   PubMed=11598075; DOI=10.1128/iai.69.11.6999-7009.2001;
RA   Paton A.W., Srimanote P., Woodrow M.C., Paton J.C.;
RT   "Characterization of Saa, a novel autoagglutinating adhesin produced by
RT   locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli
RT   strains that are virulent for humans.";
RL   Infect. Immun. 69:6999-7009(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=O29;
RX   PubMed=17101670; DOI=10.1128/iai.01336-06;
RA   Morinaga N., Yahiro K., Matsuura G., Watanabe M., Nomura F., Moss J.,
RA   Noda M.;
RT   "Two distinct cytotoxic activities of subtilase cytotoxin produced by
RT   Shiga-toxigenic Escherichia coli.";
RL   Infect. Immun. 75:488-496(2007).
RN   [3]
RP   PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION, SUBUNIT, SUBCELLULAR LOCATION,
RP   OPERON, AND DISRUPTION PHENOTYPE.
RC   STRAIN=O113:H21 / 98NK2 / STEC; PLASMID=megaplasmid pO113;
RX   PubMed=15226357; DOI=10.1084/jem.20040392;
RA   Paton A.W., Srimanote P., Talbot U.M., Wang H., Paton J.C.;
RT   "A new family of potent AB(5) cytotoxins produced by Shiga toxigenic
RT   Escherichia coli.";
RL   J. Exp. Med. 200:35-46(2004).
RN   [4]
RP   ERRATUM OF PUBMED:15226357.
RX   DOI=10.1084/jem.20040392111204c;
RA   Paton A.W., Srimanote P., Talbot U.M., Wang H., Paton J.C.;
RT   "A new family of potent AB(5) cytotoxins produced by Shiga toxigenic
RT   Escherichia coli.";
RL   J. Exp. Med. 200:1525-1525(2004).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17024087; DOI=10.1038/nature05124;
RA   Paton A.W., Beddoe T., Thorpe C.M., Whisstock J.C., Wilce M.C.,
RA   Rossjohn J., Talbot U.M., Paton J.C.;
RT   "AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone
RT   BiP.";
RL   Nature 443:548-552(2006).
RN   [6]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18042253; DOI=10.1111/j.1462-5822.2007.01085.x;
RA   Chong D.C., Paton J.C., Thorpe C.M., Paton A.W.;
RT   "Clathrin-dependent trafficking of subtilase cytotoxin, a novel AB5 toxin
RT   that targets the endoplasmic reticulum chaperone BiP.";
RL   Cell. Microbiol. 10:795-806(2008).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18005237; DOI=10.1111/j.1462-5822.2007.01094.x;
RA   Morinaga N., Yahiro K., Matsuura G., Moss J., Noda M.;
RT   "Subtilase cytotoxin, produced by Shiga-toxigenic Escherichia coli,
RT   transiently inhibits protein synthesis of Vero cells via degradation of BiP
RT   and induces cell cycle arrest at G1 by downregulation of cyclin D1.";
RL   Cell. Microbiol. 10:921-929(2008).
RN   [8]
RP   FUNCTION.
RX   PubMed=18433465; DOI=10.1111/j.1462-5822.2008.01164.x;
RA   Wolfson J.J., May K.L., Thorpe C.M., Jandhyala D.M., Paton J.C.,
RA   Paton A.W.;
RT   "Subtilase cytotoxin activates PERK, IRE1 and ATF6 endoplasmic reticulum
RT   stress-signalling pathways.";
RL   Cell. Microbiol. 10:1775-1786(2008).
RN   [9]
RP   FUNCTION.
RX   PubMed=19380466; DOI=10.1128/iai.01510-08;
RA   Matsuura G., Morinaga N., Yahiro K., Komine R., Moss J., Yoshida H.,
RA   Noda M.;
RT   "Novel subtilase cytotoxin produced by Shiga-toxigenic Escherichia coli
RT   induces apoptosis in Vero cells via mitochondrial membrane damage.";
RL   Infect. Immun. 77:2919-2924(2009).
RN   [10] {ECO:0007744|PDB:3DWA, ECO:0007744|PDB:3DWP, ECO:0007744|PDB:3DWQ}
RP   X-RAY CRYSTALLOGRAPHY (2.08 ANGSTROMS) OF 24-141 IN COMPLEX WITH
RP   N-GLYCOLOYL-ALPHA-NEURAMINIC ACID, SUBUNIT, MUTAGENESIS OF SER-35; GLN-59
RP   AND TYR-101, AND GLYCAN-BINDING.
RX   PubMed=18971931; DOI=10.1038/nature07428;
RA   Byres E., Paton A.W., Paton J.C., Lofling J.C., Smith D.F., Wilce M.C.,
RA   Talbot U.M., Chong D.C., Yu H., Huang S., Chen X., Varki N.M., Varki A.,
RA   Rossjohn J., Beddoe T.;
RT   "Incorporation of a non-human glycan mediates human susceptibility to a
RT   bacterial toxin.";
RL   Nature 456:648-652(2008).
RN   [11] {ECO:0007744|PDB:4BWG}
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 24-141 IN COMPLEX WITH SUBA,
RP   SUBUNIT, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF VAL-38; TYR-89;
RP   TYR-91; THR-92; GLY-94 AND GLN-95.
RX   PubMed=23921389; DOI=10.1074/jbc.m113.462622;
RA   Le Nours J., Paton A.W., Byres E., Troy S., Herdman B.P., Johnson M.D.,
RA   Paton J.C., Rossjohn J., Beddoe T.;
RT   "Structural basis of subtilase cytotoxin SubAB assembly.";
RL   J. Biol. Chem. 288:27505-27516(2013).
CC   -!- FUNCTION: Receptor-binding subunit of subtilase cytotoxin SubAB5.
CC       Required for receptor-binding and thus correct trafficking in the host
CC       cell (PubMed:18042253, PubMed:17024087). Has specificity for host
CC       glycans terminating in the sialic acid N-glycolyl-alpha-neuraminic acid
CC       (Neu5Gc); each subunit in the SubB pentamer binds one Neu5Gc
CC       (PubMed:18971931). The protease subunit (SubA) cleaves host BiP/HSPA5,
CC       inducing the host endoplasmic reticulum stress response and eventual
CC       cell death (PubMed:18005237, PubMed:18433465). Culture supernatant of
CC       E.coli expressing both subA and subB are toxic for Vero cells (African
CC       green monkey kidney cell line), Chinese hamster ovary cells and Hct-8
CC       cells (human colonic epithelial cell line); the subunits are not toxic
CC       individually (PubMed:15226357). Purified SubAB5 is highly toxic, <0.1
CC       pg is able to kill at least 50% of 30'000 Vero cells in a microtiter
CC       plate assay after 3 days; no cytotoxicity is seen at 24 hours
CC       (PubMed:15226357). Preabsorption with cells expressing a ganglioside
CC       GM2 mimic reduced cytotoxicity of SubAB5 by 93% in the Vero
CC       cytotoxicity assay (PubMed:15226357). Intraperitoneal injection of 200
CC       ng of purified SubAB5 kills mice; the higher the dose the faster the
CC       mice die. Animals injected with purified SubAB5 have microvascular
CC       thrombi in the brain and other organs, including the renal tubules and
CC       glomeruli. Mice fed E.coli cells expressing cloned SubAB5 experience
CC       drastic weight loss and appear ill and lethargic (PubMed:15226357).
CC       SubB alone at 2.5 ug/ml causes vacuolation of Vero cells, which
CC       requires the V-type ATPase proton pump; treated cells die
CC       (PubMed:17101670). Protein synthesis in Vero cells is transiently
CC       inhibited by SubAB5; both subunits are required for this effect
CC       (PubMed:17101670, PubMed:18005237, PubMed:18433465). Inhibition of
CC       protein synthesis is prevented by brefeldin A; cells are arrested in
CC       the G1 phase (PubMed:18005237). SubAB5 at 100 ng/ml induced caspase-
CC       dependent apoptosis in Vero cells through mitochondrial membrane damage
CC       (PubMed:19380466). {ECO:0000269|PubMed:15226357,
CC       ECO:0000269|PubMed:17101670, ECO:0000269|PubMed:18005237,
CC       ECO:0000269|PubMed:18042253, ECO:0000269|PubMed:18433465,
CC       ECO:0000269|PubMed:18971931, ECO:0000269|PubMed:19380466,
CC       ECO:0000305|PubMed:17024087}.
CC   -!- SUBUNIT: Forms a complex with SubA with the stoichiometry SubA1:SubB5
CC       (called SubAB5) (PubMed:15226357, PubMed:23921389). Each SubB subunit
CC       makes different contacts with the single SubA subunit
CC       (PubMed:23921389). This subunit alone forms pentamers
CC       (PubMed:18971931). {ECO:0000269|PubMed:18971931,
CC       ECO:0000269|PubMed:23921389, ECO:0000305|PubMed:15226357}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15226357}. Host
CC       cytoplasm, host cytosol {ECO:0000269|PubMed:15226357,
CC       ECO:0000269|PubMed:17101670}. Host endoplasmic reticulum lumen
CC       {ECO:0000305|PubMed:17024087, ECO:0000305|PubMed:18005237,
CC       ECO:0000305|PubMed:23921389}. Note=Colocalizes with host BiP/HSPA5 in
CC       the endoplasmic reticulum of Vero cells, its activity on BiP/HSPA5 is
CC       blocked by pretreatment with brefeldin A, which disrupts the Golgi
CC       apparatus and inhibits retrograde transport from the cell surface to
CC       the Golgi (PubMed:17024087, PubMed:18005237). Using different
CC       inhibitors it has been shown to be actively internalized by membrane-
CC       bound vesicles and undergoes clathrin-dependent retrograde transport,
CC       via early endosomes and the Golgi network, to the endoplasmic reticulum
CC       (PubMed:18042253). Trafficking is similar in Vero cells, human HeLa
CC       cells and murine N2A cells (PubMed:18042253).
CC       {ECO:0000269|PubMed:15226357, ECO:0000269|PubMed:17024087,
CC       ECO:0000269|PubMed:18005237, ECO:0000269|PubMed:18042253}.
CC   -!- INDUCTION: Part of the subA-subB operon (PubMed:15226357).
CC       {ECO:0000269|PubMed:15226357}.
CC   -!- DOMAIN: A patch of hydrophobic and neutral of amino acids (residues 89-
CC       94) forms a ring around the central pore of the pentamer, which
CC       interacts with the A2 helix of the SubA subunit; some mutations in this
CC       patch prevent SubAB5 complex formation but still allow some targeting
CC       to the host endoplasmic reticulum lumen (PubMed:23921389). One residue
CC       in this patch, Thr-92, is the only residue that contacts SubA from all
CC       5 of the SubB subunits (PubMed:23921389).
CC       {ECO:0000269|PubMed:23921389}.
CC   -!- DISRUPTION PHENOTYPE: No longer toxic to CHO cells when deletion
CC       construct is coexpressed with subA (PubMed:15226357).
CC       {ECO:0000269|PubMed:15226357}.
CC   -!- MISCELLANEOUS: The E.coli strain this operon was isolated from causes
CC       hemolytic uremic syndrome (HUS) and also encodes a Shigella-type toxin
CC       Stx. {ECO:0000303|PubMed:15226357}.
CC   -!- MISCELLANEOUS: Humans cannot convert CMP-Neu5Ac to CMP-Neu5Gc due to a
CC       mutation in the CMAHP gene, and so should be less susceptible to this
CC       toxin than other animals. However Neu5Gc can be acquired from red meat
CC       and milk products, resulting in Neu5Gc incorporation into human tissue
CC       (PubMed:18971931). {ECO:0000303|PubMed:18971931}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF399919; AAT68784.1; -; Genomic_DNA.
DR   PDB; 3DWA; X-ray; 2.08 A; A/B/C/D/E=24-141.
DR   PDB; 3DWP; X-ray; 2.20 A; A/B/C/D/E=24-141.
DR   PDB; 3DWQ; X-ray; 2.10 A; A/B/C/D/E=24-141.
DR   PDB; 4BWG; X-ray; 2.60 A; B/C/D/E/F/H/I/J/K/L=24-141.
DR   PDBsum; 3DWA; -.
DR   PDBsum; 3DWP; -.
DR   PDBsum; 3DWQ; -.
DR   PDBsum; 4BWG; -.
DR   AlphaFoldDB; Q6EZC3; -.
DR   SMR; Q6EZC3; -.
DR   UniLectin; Q6EZC3; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0044164; C:host cell cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0044166; C:host cell endoplasmic reticulum lumen; IMP:UniProtKB.
DR   GO; GO:0033691; F:sialic acid binding; IDA:UniProtKB.
DR   InterPro; IPR008992; Enterotoxin.
DR   SUPFAM; SSF50203; SSF50203; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Host cytoplasm;
KW   Host endoplasmic reticulum; Plasmid; Secreted; Signal; Virulence.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255, ECO:0000305|PubMed:15226357"
FT   CHAIN           24..141
FT                   /note="Subtilase cytotoxin subunit B"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5004273050"
FT   REGION          89..94
FT                   /note="Hydrophobic patch important for binding to SubA"
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   BINDING         33..35
FT                   /ligand="N-glycoloyl-alpha-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:176558"
FT                   /evidence="ECO:0000269|PubMed:18971931"
FT   BINDING         59
FT                   /ligand="N-glycoloyl-alpha-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:176558"
FT                   /evidence="ECO:0000269|PubMed:18971931"
FT   BINDING         101
FT                   /ligand="N-glycoloyl-alpha-neuraminate"
FT                   /ligand_id="ChEBI:CHEBI:176558"
FT                   /evidence="ECO:0000269|PubMed:18971931"
FT   VARIANT         102
FT                   /note="K -> E (in strain: O29)"
FT                   /evidence="ECO:0000269|PubMed:17101670"
FT   MUTAGEN         35
FT                   /note="S->A: Reduced toxicity of SubAB5 for Vero cells over
FT                   99%, no longer binds to Vero cells, decreased binding to
FT                   human colon sections."
FT                   /evidence="ECO:0000269|PubMed:18971931"
FT   MUTAGEN         38
FT                   /note="V->A: 50% toxicity of holotoxin on Vero cells,
FT                   SubAB5 complex about 60% less stable."
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   MUTAGEN         59
FT                   /note="Q->A: Reduced toxicity of SubAB5 for Vero cells by
FT                   87%."
FT                   /evidence="ECO:0000269|PubMed:18971931"
FT   MUTAGEN         89
FT                   /note="Y->A: Decreased localization to host endoplasmic
FT                   reticulum lumen, nearly complete loss of toxicity of
FT                   holotoxin on Vero cells, SubAB5 complex about 60% less
FT                   stable."
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   MUTAGEN         91
FT                   /note="Y->A: Holotoxin does not form."
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   MUTAGEN         92
FT                   /note="T->D: Poor localization to host endoplasmic
FT                   reticulum lumen, nearly complete loss of toxicity of
FT                   holotoxin on Vero cells, too little SubAB5 complex forms to
FT                   test its stability."
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   MUTAGEN         93
FT                   /note="T->A: No longer localizes to host endoplasmic
FT                   reticulum lumen, about 5% toxicity of holotoxin on Vero
FT                   cells, SubAB5 complex about 60% less stable."
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   MUTAGEN         93
FT                   /note="T->D: Decreased localization to host endoplasmic
FT                   reticulum lumen, loss of toxicity of holotoxin on Vero
FT                   cells, SubAB5 complex about 50% less stable."
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   MUTAGEN         94
FT                   /note="G->A: 50% toxicity of holotoxin on Vero cells, too
FT                   little SubAB5 complex forms to test its stability."
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   MUTAGEN         94
FT                   /note="G->D: Holotoxin does not form."
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   MUTAGEN         95
FT                   /note="Q->A: About 25% toxicity of holotoxin on Vero cells,
FT                   SubAB5 complex about 50% less stable."
FT                   /evidence="ECO:0000269|PubMed:23921389"
FT   MUTAGEN         101
FT                   /note="Y->F: Reduced toxicity of SubAB5 for Vero cells by
FT                   97%, greatly reduced binding to Vero cells, decreased
FT                   binding to human kidney sections."
FT                   /evidence="ECO:0000269|PubMed:18971931"
SQ   SEQUENCE   141 AA;  15409 MW;  C221950EC4A3992D CRC64;
     MTIKRFFVCA GIMGCLSLNP AMAEWTGDAR DGMFSGVVIT QFHTGQIDNK PYFCIEGKQS
     AGSSISACSM KNSSVWGASF STLYNQALYF YTTGQPVRIY YKPGVWTYPP FVKALTSNAL
     VGLSTCTTST ECFGPDRKKN S
//
